RPHM - Reneo Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Reneo Pharmaceuticals's activity chart (see below) currently has 15 price targets and 16 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 86.36% with an average time for these price targets to be met of 169.91 days.

Most recent stock forecast was given by from HC WAINWRIGHT on 14-May-2024. First documented stock forecast 04-May-2021.

Best performing analysts who are covering RPHM - Reneo Pharmaceuticals:

Eun Yang Yasmeen Rahimi Mitchell Kapoor Gobind Singh Joseph Schwartz Brian Skorney

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 14-May-2024

$30

2 years 3 months 26 days ago
(14-May-2024)

3/4 (75%)

$15.8 (111.27%)

67

$1.8

$-0.02 (-1.10%)

$24

2 years 8 months 25 days ago
(15-Dec-2023)

2/2 (100%)

$-12.4 (-87.32%)

321

Hold Since 15-Dec-2023

$15

2 years 8 months 25 days ago
(15-Dec-2023)

1/1 (100%)

$-19.9 (-57.02%)

630

Buy Since 04-May-2021

$4

$2.18 (119.78%)

2 years 8 months 26 days ago
(14-Dec-2023)

5/5 (100%)

$-9.4 (-70.15%)

222

Buy Since 19-Sep-2022

$30

$28.18 (1548.35%)

$30

3 years 1 days ago
(08-Sep-2023)

3/3 (100%)

$-41.1 (-57.81%)

71

Show more analysts

Please expand the browser size to see the chart

What is RPHM (Reneo Pharmaceuticals) average time for price targets to be met?

On average it took 170 days for the stock forecasts to be reached, with an average price target met ratio of 86.36%.

Which analyst most recently updated their price target on RPHM (Reneo Pharmaceuticals)?

Which analyst has the most public recommendations on RPHM (Reneo Pharmaceuticals)?

has 0 price targets and 0 ratings on RPHM

Which analyst is the currently most bullish on RPHM (Reneo Pharmaceuticals)?

Matthew Kaplan with the highest potential upside of $43.18

Which analyst is the currently most reserved on RPHM (Reneo Pharmaceuticals)?

Eun Yang with the lowest potential downside of -$0.02

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?